A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.
|Articles|April 3, 2012
Poll: Do you Recommend IUDs to Nulliparous Women?
Author(s)OBGYN.net Staff
A recent study shows that health care professionals continue to have misconceptions about the safety of IUDs for nulliparous women.
Advertisement
A recently published
Advertisement
Related to this article
A recap of Contemporary OB/GYN's top FDA and regulatory news from September 2026.
Anita Nelson, MD, discusses the FDA's approval extending etonogestrel implant use to 5 years and the new REMS certification clinicians must complete by February 23, 2027.
Pritelivir healed all HSV lesions by day 28 in 63% of immunocompromised adults vs 34% with comparators.
Fezolinetant (Veozah) was linked to objective and patient-reported sleep gains in OPTION-VMS, with no new safety signals observed.
HPV vaccination before pregnancy was linked to lower odds of preterm birth in a Swedish study of 624,713 births.
The prospective SOARA study will measure how often a 98%-specific ovarian cancer screening blood test leads to invasive procedures.
A new 3-part Lancet series reframes pregnancy as a cardiovascular risk window.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves pritelivir tablets to treat lesions from HSV
2
Perimenopause and mental health: Beyond hormonal vs psychological
3
HPV vaccine before pregnancy tied to fewer adverse pregnancy outcomes
4
Ultrasound findings after medication management of early pregnancy loss
5